← Leaderboards
Sandra Kelly Avants
Apt Foundation, Inc.
$1,382,707
Attributed
$1,382,707
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,382,707 · 2
By mechanism
R01$1,382,707 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchOpiate AlkaloidDrug Abuse ChemotherapyHigh Risk Behavior /LifestyleBehavior ModificationMethadoneBehavioral /Social Science Research TagHuman SubjectCognition DisordersLongitudinal Human StudyComorbidityCopingDisease /Disorder Proneness /RiskAnxiety DisordersDrug AddictionAids Education /PreventionUrinalysisCognitionCognitive Behavior TherapyCombination TherapyDrug AbuseDrug Abuse EducationFunctional Ability
Grant awards (4)
REDUCING HIV RISK IN METHADONE-MAINTAINED PATIENTS$309,277
R01 · FY2002 · DA
REDUCING HIV RISK IN METHADONE-MAINTAINED PATIENTS$354,294
R01 · FY2001 · DA
REDUCING HIGH RISK BEHAVIOR IN HIV POSITIVE DRUG ABUSER$384,066
R01 · FY2000 · DA
REDUCING HIV RISK IN METHADONE-MAINTAINED PATIENTS$335,070
R01 · FY2000 · DA